The pharmaceuticals, biotechnology and medical device industries are among the world's most important sectors and are key contributors to healthcare and the global economy. As you know, the environment in which you operate is increasingly challenging, being driven by a more demanding healthcare agenda and current economic conditions. The global need for innovative, cost effective medicines and devices continues to rise while regulators, payers, health care providers and patients are demanding greater value for money, proven effectiveness of products, more transparency and access to information. To meet these demands, companies are seeking ways to increase the efficiency of their operations, reduce cost of doing business, re-evaluate financing strategy, look for strong M&A opportunities to support strategic goals and deal with the changing financial reporting environment, such as an impact of fair value.

As the leader in providing professional audit, tax and advisory services to the pharmaceutical and life sciences sector, PricewaterhouseCoopers is continually thinking about these issues as well. In 2009, we are commencing a series of discussions around these issues to help our clients think through not only the changes, problems and solutions of today, but those of tomorrow as well. 

This series will offer a sharing of the point of view of a firm recognized as an industry thought leader, and the opportunity for a vigorous dialogue with Firm experts as well as your colleagues who face similar challenges.

Please join us for the following series of events:

Please direct questions regarding this event to Lisa Gaston at 415-498-5389 or via email at lisa.gaston@us.pwc.com.

We look forward to seeing you at one of our sessions.